These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24335304)

  • 1. Enhanced fusion and virion incorporation for HIV-1 subtype C envelope glycoproteins with compact V1/V2 domains.
    Cavrois M; Neidleman J; Santiago ML; Derdeyn CA; Hunter E; Greene WC
    J Virol; 2014 Feb; 88(4):2083-94. PubMed ID: 24335304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model for alignment of Env V1 and V2 hypervariable domains from human and simian immunodeficiency viruses.
    Lamers SL; Sleasman JW; Goodenow MM
    AIDS Res Hum Retroviruses; 1996 Aug; 12(12):1169-78. PubMed ID: 8844021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turnover of env variable region 1 and 2 genotypes in subjects with late-stage human immunodeficiency virus type 1 infection.
    Kitrinos KM; Hoffman NG; Nelson JA; Swanstrom R
    J Virol; 2003 Jun; 77(12):6811-22. PubMed ID: 12768001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo.
    Lamers SL; Sleasman JW; She JX; Barrie KA; Pomeroy SM; Barrett DJ; Goodenow MM
    J Virol; 1993 Jul; 67(7):3951-60. PubMed ID: 8510212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of the fusion efficiency elicited by the envelope glycoprotein V1-V5 regions derived from human immunodeficiency virus type 1 transmitted perinatally.
    Guo H; Abrahamyan LG; Liu C; Waltke M; Geng Y; Chen Q; Wood C; Kong X
    J Gen Virol; 2012 Dec; 93(Pt 12):2635-2645. PubMed ID: 22956734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth.
    Smith SA; Burton SL; Kilembe W; Lakhi S; Karita E; Price M; Allen S; Hunter E; Derdeyn CA
    PLoS Pathog; 2016 Nov; 12(11):e1005989. PubMed ID: 27851829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Highly Unusual V1 Region of Env in an Elite Controller of HIV Infection.
    Silver ZA; Dickinson GM; Seaman MS; Desrosiers RC
    J Virol; 2019 May; 93(10):. PubMed ID: 30842322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response.
    Quiñones-Kochs MI; Buonocore L; Rose JK
    J Virol; 2002 May; 76(9):4199-211. PubMed ID: 11932385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.
    LaBranche CC; Hoffman TL; Romano J; Haggarty BS; Edwards TG; Matthews TJ; Doms RW; Hoxie JA
    J Virol; 1999 Dec; 73(12):10310-9. PubMed ID: 10559349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity.
    Sagar M; Wu X; Lee S; Overbaugh J
    J Virol; 2006 Oct; 80(19):9586-98. PubMed ID: 16973562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1.
    Liao HX; Tsao CY; Alam SM; Muldoon M; Vandergrift N; Ma BJ; Lu X; Sutherland LL; Scearce RM; Bowman C; Parks R; Chen H; Blinn JH; Lapedes A; Watson S; Xia SM; Foulger A; Hahn BH; Shaw GM; Swanstrom R; Montefiori DC; Gao F; Haynes BF; Korber B
    J Virol; 2013 Apr; 87(8):4185-201. PubMed ID: 23365441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation of native epitopes in the V1/V2 and V3 regions of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains.
    Kayman SC; Wu Z; Revesz K; Chen H; Kopelman R; Pinter A
    J Virol; 1994 Jan; 68(1):400-10. PubMed ID: 7504740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of low CD4 levels in the influence of human immunodeficiency virus type 1 envelope V1 and V2 regions on entry and spread in macrophages.
    Walter BL; Wehrly K; Swanstrom R; Platt E; Kabat D; Chesebro B
    J Virol; 2005 Apr; 79(8):4828-37. PubMed ID: 15795268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread.
    Toohey K; Wehrly K; Nishio J; Perryman S; Chesebro B
    Virology; 1995 Oct; 213(1):70-9. PubMed ID: 7483281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of human immunodeficiency virus type 1 envelope glycoproteins with V1/V2 deleted, using virus evolution.
    Bontjer I; Land A; Eggink D; Verkade E; Tuin K; Baldwin C; Pollakis G; Paxton WA; Braakman I; Berkhout B; Sanders RW
    J Virol; 2009 Jan; 83(1):368-83. PubMed ID: 18922866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular epidemiology of HIV-1 envelope diversity during HIV-1 subtype C vertical transmission in Malawian mother-infant pairs.
    Kwiek JJ; Russell ES; Dang KK; Burch CL; Mwapasa V; Meshnick SR; Swanstrom R
    AIDS; 2008 Apr; 22(7):863-71. PubMed ID: 18427205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses.
    Kraft Z; Strouss K; Sutton WF; Cleveland B; Tso FY; Polacino P; Overbaugh J; Hu SL; Stamatatos L
    J Virol; 2008 Jun; 82(12):5912-21. PubMed ID: 18400850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
    Wyatt R; Moore J; Accola M; Desjardin E; Robinson J; Sodroski J
    J Virol; 1995 Sep; 69(9):5723-33. PubMed ID: 7543586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120.
    Freed EO; Martin MA
    J Virol; 1994 Apr; 68(4):2503-12. PubMed ID: 8139032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions.
    Zhang S; Nguyen HT; Ding H; Wang J; Zou S; Liu L; Guha D; Gabuzda D; Ho DD; Kappes JC; Sodroski J
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33148792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.